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TO THE EDITOR
Striae distensae, or stretch marks, are a
common skin condition that appear
initially as red, and later on as white,
lines on the skin. These lines represent
scars of the dermis, and are character-
ized by linear bundles of collagen lying
parallel to the surface of the skin, as well
as eventual loss of collagen and elastin.
Reports differ on the level of fragmenta-
tion of elastic fibers (Zheng et al., 1985;
Sheu et al., 1991). Estimates of the
prevalence of stretch marks range from
50 to 80% (Atwal et al., 2006; Cho
et al., 2006). Although stretch marks are
only harmful in extreme cases (Dosal
et al., 2012), even mild stretch marks
can cause distress to the bearer.
The causes of stretch marks are not
well understood. Excessive skin
distension (such as that which occurs
during pregnancy, growth spurts in pub-
erty, or rapid weight gain), prolonged
exposure to cortisol (such as in indivi-
duals with Cushing syndrome), and
genetics may all have a role (Elsaie
et al., 2009). A few monogenic connec-
tive tissue diseases, including Marfan
syndrome and congenital contractural
arachnodactyly, are known to be
associated with stretch marks. These
syndromes are caused by mutations in
genes that encode extracellular matrix
proteins (fibrillin-1 and fibrillin-2,
respectively) that are part of elastic
microfibrils present in skin and other
tissues. However, to date, no genetic
variants are known to be associated with
isolated stretch marks that afflict the
general population.
To identify variants associated with
the development of stretch marks, we
conducted a genome-wide association
analysis of stretch marks in a discovery
cohort of 33,930 unrelated 23andMe
customers (Supplementary Table S1
online) of European descent. There
were a total of 13,068 cases and
20,862 controls. The 18,650 men in
the cohort were much less likely to
report stretch marks (25% versus 55%
of women), which is consistent with
other reports (Elsaie et al., 2009).
We further evaluated the associated
variants in a cohort consisting of 4,967
female 23andMe customers of
European descent (disjoint from the
first group) who reported on severity of
stretch marks during pregnancy (also
known as striae gravidarum, a closely
related phenotype). See Supplemental
Methods for additional details on
phenotyping. The protocol for this
study was approved by an independent
institutional review board (E&I Review
Services) and was conducted accord-
ing to the Declaration of Helsinki
Principles; all study participants pro-
vided informed consent online, which
was recorded in an electronic database.
See Supplementary Methods for details
on genotyping and imputation. All
analyses used logistic (discovery cohort)
or linear (pregnancy cohort) regression
against imputed allele dosages, con-
trolling for age, population structure
(using five principal components), and
(except for the pregnancy cohort) sex.
Because the prevalence of stretch marks
differs between men and women, we
checked for but did not observe differ-
ing effects for the single-nucleo-
tide polymorphisms (SNPs) in men and
women.
Four regions were significantly
(Po5e8) associated with stretch marks
(Table 1, Figure 1, Supplementary
Figure S1 online). The most strongly
associated SNP in the first region,
rs7787362 (P¼ 1.8e 23, odds ratio
(OR)¼ 0.84), lies 40 kb upstream of the
ELN (elastin) gene. It was also asso-
ciated with striae gravidarum in the
pregnancy cohort (P¼ 7e5, b¼
 0.072, Supplementary Table S2
online). Elastin is the major component
of elastic fibers, which provide reversible
extensibility to connective tissue. Muta-
tions in elastin that result in a loss of
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mature elastin can lead to autosomal
dominant cutis laxa (a condition char-
acterized by loose, sagging skin, and
higher risks of aortic aneurysm) or supra-
valvular aortic stenosis (a localized
narrowing of the ascending aorta caused
by thickening of the aortic smooth mus-
cle layer to compensate for the loss of
elastin; Milewicz et al., 2000). ELN is
also one of the genes deleted in
Williams–Beuren syndrome, whose
symptoms can include lax skin and
supravalvular aortic stenosis, among
others. Duplication of the elastin gene
does not clearly lead to any skin
Table 1. Index SNPs for regions associated with striae distensae at a significance level of Po1e–6
Discovery Pregnancy
SNP Chr (pos)1 Gene2 All3 MAF4 r2 5 P6 OR (CI)7 P6 b (CI)8
rs7787362* 7 (73392603) ELN (u) C/T 0.467 0.992 1.8E 23 0.84 (0.81–0.87) 7e5 0.072 (0.053–0.091)
rs35318931 X (38009121) SRPX (i) G/A 0.079 0.964 1.1E 13 0.82 (0.77–0.86) 0.026 0.067 (0.033–0.102)
rs10798036 1 (186052962) HMCN1 (i) G/C 0.485 0.989 6.9E 10 1.11 (1.08–1.15) 0.06  0.029 ( 0.048 to 0.010)
rs7594220 2 (643320) TMEM18 (d) A/G 0.194 0.946 9.8E 09 0.88 (0.84–0.92) 0.70  0.067 ( 0.192 to 0058)
chr6:36311047 6 (36311047) PNPLA1 (d) C/T 0.007 0.988 9.7E 08 1.80 (1.45–2.23)
rs3910516 2 (216303053) FN1 (u) G/A 0.262 0.909 2.7E 07 1.11 (1.07–1.16)
rs62034322 16 (28535834) NPIPL2 (i) G/A 0.359 0.946 4.7E 07 1.10 (1.06–1.14)
1Chromosome (chr) and position (pos) are with respect to build 37.
2Gene is gene that is the most likely candidate for the association or the association or the closest gene. Whether the single-nucleotide polymorphism (SNP) is
upstream (u), downstream (d), or within (i) the gene is indicated in parentheses.
3Alleles are major/minor in the context of European ancestry.
4MAF is minor allele frequency in the entire 23andMe European research cohort (over 120,000 individuals).
5r2 is the estimated imputation accuracy.
6Associations with a P-value o5e 8 are genome-wide significant, and those with P-values between 1e6 and 5e 8 are defined as suggestive.
7For the discovery set (which included both men and women), the odds ratio (OR) plus confidence interval (CI) is with respect to the minor allele and
represents the risk of developing stretch marks.
8For the pregnancy set (which included only women), the b plus CI is with respect to the major allele, with positive numbers representing an increase in the
severity of stretch marks. These tests were run only for SNPs reaching genome-wide significance in the discovery set. SNPs marked with an asterisk are typed by
our genotyping array.
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Figure 1. Manhattan plot depicting single-nucleotide polymorphism (SNP) associations with stretch marks. (a) Genome-wide view of associations. SNPs shown
in red are genome-wide significant (Po5e 8). Regions are named with the postulated candidate gene. (b) Detailed view of local region around rs7787362.
Colors depict the squared correlation (r2) of each SNP with rs7787362, shown in purple. Gray indicates SNPs for which r2 information was missing.
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phenotype (Merla et al., 2010), which
suggests that rs7787362 may be
associated with a decrease in the
expression of functional elastin,
although we did not find this SNP in a
search of eQTL databases.
The second association, rs35318931
(P¼ 1.1e 13, OR¼ 0.82), is a mis-
sense variant (serine to phenylalanine)
in the SRPX (sushi-repeat containing
protein, X-linked) gene. It is associated
with striae gravidarum in the pregnancy
cohort (P¼ 0.026, b¼  0.067). Very
little is known about the function of this
gene. The third association, rs10798036
(P¼ 6.91e10, OR¼1.11), which did
not reach significance in the pregnancy
cohort (P¼0.06), is located in the
HMCN1 (hemicentin-1) gene. Mutations
in HMCN1 have been associated
with age-related macular degeneration
(Schultz et al., 2003). As there are no
other clear gene candidates for the
associations at these loci, it is unclear
how these regions might be related to
the risk of developing stretch marks.
The final genome-wide significant
association, rs7594220 (P¼9.8e9,
OR¼0.88), is located 3 kb downstream
of TMEM18 (transmembrane protein
18), which is involved in neural stem
cell migration and cancer but has also
been associated with obesity and obesity-
related traits (Thorleifsson et al., 2009;
Elks et al., 2010). This SNP is in linkage
disequilibrium with SNPs previously
associated with body mass index (BMI),
and correcting for BMI weakens this
signal, although not the signals for the
other three genome-wide significant hits.
To further investigate the association
between obesity and stretch marks, we
looked more closely at 32 SNPs
previously associated with BMI. Even
after correction for BMI, one SNP was
associated with stretch marks, suggesting
a potential effect independent of BMI
(Supplementary Table S3 online).
Three additional regions show sugges-
tive evidence of association with stretch
marks (Table 1). Of these, rs3910516 is
of particular interest as it lies 2.2 kb
upstream of FN1, which encodes fibro-
nectin, an extracellular matrix protein
that binds to collagen and integrins. Skin
biopsies from individuals with stretch
marks demonstrate reduced expression
of fibronectin (Lee et al., 1994). The
SNP (chr6:36311047) downstream of
PNPLA1 is also interesting, as
mutations in PLPLA1 are associated
with autosomal recessive congenital
ichthyosis, a rare skin disease (Grall
et al., 2012). None of the suggestive
associations were found in the smaller
pregnancy cohort. Although we did not
observe a significant difference in the
effect of these SNPs between men and
women in the discovery cohort, it is still
possible that striae gravidarum may
have a different etiology.
Given that loose skin is a symptom of
syndromes caused by deletion or loss-
of-function mutations in ELN, our results
support the hypothesis that variations in
the elastic fiber component of the skin
extracellular matrix contribute to the
development of stretch marks. The
expression of collagens, elastin, and
fibronectin (which was suggestively
associated with stretch marks in our
analysis) is decreased in striae, which
could be linked to the reorganization
and overall loss of elastic fibers in skin
affected by striae (Lee et al., 1994;
Watson et al., 1998). Other variants
associated with elastic tissue have
been associated with intracranial
aneurysm and exfoliation glaucoma
(Akagawa et al., 2006; Thorleifsson
et al., 2007). The potential effect of
genes associated with obesity, both
independent of and via changes in
BMI, is also an intriguing area for
further study. Replicating this work in a
more precisely phenotyped population
would be a logical next step.
None of the existing treatments for
stretch marks are completely effective in
removing stretch marks. Interestingly,
most popular treatments including topi-
cal treatments and laser treatments focus
on stimulating collagen production,
rather than elastin production, to
improve the appearance of stretch
marks, although some also increase
elastic fibers (Elsaie et al., 2009). These
findings may provide further insight into
future methods for the prevention and
treatment of stretch marks.
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Six Mutations in AAGAB Confirm its Pathogenic Role in
Chinese Punctate Palmoplantar Keratoderma Patients
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TO THE EDITOR
Palmoplantar keratodermas (PPKs) are a
group of rare keratinization disorders
characterized by the excessive forma-
tion of keratin on the palms and soles.
Four clinical types of PPK can be classi-
fied by the pattern of lesions: diffuse,
punctuate, focal, and striate (Stevens
et al., 1996). Punctate palmo-
plantar keratoderma type I (PPKP1,
MIM number 148,600) is an autosomal
dominant inherited subtype of PPK
characterized by multiple tiny punctate
keratoses on the palms and soles, which
can gradually increase in diameter with
age and even coalesce (Figure 1a and b).
The incidence of this disease was
reported as 1.17 per 100,000 population
in Croatia and 3.3 per 100,000 popula-
tion in Slovenia (Guo et al., 2012). Two
linkage loci for PPKP1 (8q24.13–
8q24.21, 15q22.2–15q24.1) have been
reported previously (Martinez-Mir et al.,
2003; Zhang et al., 2004; Gao et al.,
2005; El Amri et al., 2010; Mamai et al.,
2012).
In recent years, the success of exome
sequencing has been well esta-
blished in the identification of novel
causal mutations for Mendelian diseases
(Ku et al., 2012). Here, we subjected
two DNA sequences (III8 and III9) from
the Chinese PPKP1 family linked to
15q22 (Family 22) to exome sequen-
cing. Informed consent was obtained
from all the sequenced participants.
This study was authorized by the Ethics
Committee of Anhui Medical University
and was conducted in accordance with
the Declaration of Helsinki Principles.
Exome capture and enrichment were
performed using the Agilent SureSelect
Human All Exon Kit (in solution; Santa
Clara, CA) according to the manu-
facturer’s protocols. Exome sequencing
was then performed on a HiSeq 2000
platform (Illumina, San Diego, CA), and
sequence data were processed to raw
sequence reads. These reads were
aligned to a human reference genome
(NCBI build 37.3, hg19), and the
analytical pipeline was then followed
by SOAPsnp (Li et al., 2009). Finally,
the variants were annotated to obtain
information such as genomic position
and functional effect.
On average, two sequences were
obtained from each individual at B50-
fold coverage depth. We obtained 4.51
billion bases of sequence data as paired-
end, 90-bp reads. After discarding reads
that had a duplicated start site, 2.69
billion bases of mappable targeted
exome were defined by RefSeq genes.
An average of 89.2% of the exome
was covered at least B10-fold, and
51,819 variants were identified per
individual.
We primarily focused on coding
variants, including non-synonymous
variants, splice-site variants, and inser-
tions/deletions, of which there were an
average of 11,362. We filtered the
variants against dbSNP129, eight Hap-
Map individuals, the 1,000 Genomes
Project, the YH database, and unaf-
fected individual, and reduced the
number of candidate variants to 527.
We then used SIFT to predict the func-
tional impact and determine the 261
variants that were the most likely to be
damaging. Finally, we found that five
mutations in five genes (DAPK2,
IGDCC4, RPL4, TPM1, and AAGAB)
were located on 15q22.2–15q24.1.
Among the five genes, mutations in
AAGAB have recently been identified
in PPKP1 in two publications (Giehl
et al., 2012; Pohler et al., 2012). We
tested all the samples and identified the
c.552_554TAG4AT mutation in exon 6
of AAGAB as the causative mutation in
Family 22 (Figure 1c and d). This muta-
tion resulted in a stop codon at amino
acid position 188 (p.Phe184 Leufs* 6).
We then sequenced all the exons and
exon–intron boundaries of AAGAB in
59 individuals from an additional seven
families (Families 23–29) and 28
sporadic patients (Sporadic patients
1–28) with PPKP1 (Supplementary
Figure S1 online). Finally, four truncated
mutations in four respective families and
a splice-site mutation in one sporadic
case were identified (Supplementary
Figure S2 online). The AAGAB gene
mutations were absent in three other
PPKP1 families (Families 27–29) and
27 sporadic patients (Sporadic patients
2–28). In addition, we identified the
c.481C4T mutation in exon 5 in one
patient with cancer from Family 24,Accepted article preview online 30 April 2013; published online 13 June 2013
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